BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 16107887)

  • 21. Truncated ALK derived from chromosomal translocation t(2;5)(p23;q35) binds to the SH3 domain of p85-PI3K.
    Polgar D; Leisser C; Maier S; Strasser S; Rüger B; Dettke M; Khorchide M; Simonitsch I; Cerni C; Krupitza G
    Mutat Res; 2005 Feb; 570(1):9-15. PubMed ID: 15680399
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anaplastic lymphoma kinase-positive large B-cell lymphoma with complex karyotype and novel ALK gene rearrangements.
    Shi M; Miron PM; Hutchinson L; Woda BA; Nath R; Cerny J; Yu H
    Hum Pathol; 2011 Oct; 42(10):1562-7. PubMed ID: 21497367
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A new variant anaplastic lymphoma kinase (ALK)-fusion protein (ATIC-ALK) in a case of ALK-positive anaplastic large cell lymphoma.
    Trinei M; Lanfrancone L; Campo E; Pulford K; Mason DY; Pelicci PG; Falini B
    Cancer Res; 2000 Feb; 60(4):793-8. PubMed ID: 10706082
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serpin A1 is overexpressed in ALK+ anaplastic large cell lymphoma and its expression correlates with extranodal dissemination.
    Duplantier MM; Lamant L; Sabourdy F; de Reynies A; Delsol G; Espinos E
    Leukemia; 2006 Oct; 20(10):1848-54. PubMed ID: 16900211
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The expression of CD30 in anaplastic large cell lymphoma is regulated by nucleophosmin-anaplastic lymphoma kinase-mediated JunB level in a cell type-specific manner.
    Hsu FY; Johnston PB; Burke KA; Zhao Y
    Cancer Res; 2006 Sep; 66(18):9002-8. PubMed ID: 16982741
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Global proteome profiling of NPM/ALK-positive anaplastic large cell lymphoma.
    Sjostrom C; Seiler C; Crockett DK; Tripp SR; Elenitoba Johnson KS; Lim MS
    Exp Hematol; 2007 Aug; 35(8):1240-8. PubMed ID: 17560012
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High expression of several tyrosine kinases and activation of the PI3K/AKT pathway in mediastinal large B cell lymphoma reveals further similarities to Hodgkin lymphoma.
    Renné C; Willenbrock K; Martin-Subero JI; Hinsch N; Döring C; Tiacci E; Klapper W; Möller P; Küppers R; Hansmann ML; Siebert R; Bräuninger A
    Leukemia; 2007 Apr; 21(4):780-7. PubMed ID: 17375124
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Selective inhibition of STAT3 induces apoptosis and G(1) cell cycle arrest in ALK-positive anaplastic large cell lymphoma.
    Amin HM; McDonnell TJ; Ma Y; Lin Q; Fujio Y; Kunisada K; Leventaki V; Das P; Rassidakis GZ; Cutler C; Medeiros LJ; Lai R
    Oncogene; 2004 Jul; 23(32):5426-34. PubMed ID: 15184887
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunohistochemical screening for oncogenic tyrosine kinase activation.
    Pulford K; Delsol G; Roncador G; Biddolph S; Jones M; Mason DY
    J Pathol; 1999 Apr; 187(5):588-93. PubMed ID: 10398126
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A case of primary cutaneous anaplastic large cell lymphoma with variant anaplastic lymphoma kinase translocation.
    Sasaki K; Sugaya M; Fujita H; Takeuchi K; Torii H; Asahina A; Tamaki K
    Br J Dermatol; 2004 Jun; 150(6):1202-7. PubMed ID: 15214912
    [TBL] [Abstract][Full Text] [Related]  

  • 31. TPM3-ALK expression induces changes in cytoskeleton organisation and confers higher metastatic capacities than other ALK fusion proteins.
    Armstrong F; Lamant L; Hieblot C; Delsol G; Touriol C
    Eur J Cancer; 2007 Mar; 43(4):640-6. PubMed ID: 17276053
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 5'-(RACE) identification of rare ALK fusion partner in anaplastic large cell lymphoma.
    Reading NS; Jenson SD; Smith JK; Lim MS; Elenitoba-Johnson KS
    J Mol Diagn; 2003 May; 5(2):136-40. PubMed ID: 12707379
    [No Abstract]   [Full Text] [Related]  

  • 33. Pediatric ALK+ anaplastic large cell lymphoma with t(3;8)(q26.2;q24) translocation and c-myc rearrangement terminating in a leukemic phase.
    Monaco S; Tsao L; Murty VV; Nandula SV; Donovan V; Oesterheld J; Bhagat G; Alobeid B
    Am J Hematol; 2007 Jan; 82(1):59-64. PubMed ID: 16955462
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Downregulation of NPM-ALK by siRNA causes anaplastic large cell lymphoma cell growth inhibition and augments the anti cancer effects of chemotherapy in vitro.
    Hsu FY; Zhao Y; Anderson WF; Johnston PB
    Cancer Invest; 2007 Jun; 25(4):240-8. PubMed ID: 17612934
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High expression of Mcl-1 in ALK positive and negative anaplastic large cell lymphoma.
    Rust R; Harms G; Blokzijl T; Boot M; Diepstra A; Kluiver J; Visser L; Peh SC; Lim M; Kamps WA; Poppema S; van den Berg A
    J Clin Pathol; 2005 May; 58(5):520-4. PubMed ID: 15858125
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Primary leptomeningeal ALK+ lymphoma in a 13-year-old child.
    Merlin E; Chabrier S; Verkarre V; Cramer E; Delabesse E; Stéphan JL
    J Pediatr Hematol Oncol; 2008 Dec; 30(12):963-7. PubMed ID: 19131793
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Distribution of NPM1-ALK and X-ALK fusion transcripts in paediatric anaplastic large cell lymphoma: a molecular-histological correlation.
    Damm-Welk C; Klapper W; Oschlies I; Gesk S; Röttgers S; Bradtke J; Siebert R; Reiter A; Woessmann W
    Br J Haematol; 2009 Aug; 146(3):306-9. PubMed ID: 19545284
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nodal ALK positive anaplastic large cell lymphoma of the axilla with spontaneous regression.
    Patel P; Godwin J; Velankar M; Alkan S
    Leuk Lymphoma; 2007 Jun; 48(6):1250-2. PubMed ID: 17577798
    [No Abstract]   [Full Text] [Related]  

  • 39. Clinicopathological correlation, p16-p15 methylation status and outcome predictors in anaplastic large cell lymphoma.
    García MJ; Castrillo JM; Granizo JJ; Cazorla A; Rivas C
    Br J Haematol; 2002 Dec; 119(3):877-8. PubMed ID: 12437676
    [No Abstract]   [Full Text] [Related]  

  • 40. [ALK positive large B-cell lymphoma: a case report].
    Li M; Gao ZF
    Zhonghua Xue Ye Xue Za Zhi; 2012 Jul; 33(7):565. PubMed ID: 22967419
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.